Cite
Efficacy and safety of anlotinib as maintenance treatment in extensive-stage small cell lung cancer: a single-armed single center retrospective study.
MLA
Xiong, Jin, and Lei Xia. “Efficacy and Safety of Anlotinib as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer: A Single-Armed Single Center Retrospective Study.” Frontiers in Oncology, Jan. 2025, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fonc.2024.1462581.
APA
Xiong, J., & Xia, L. (2025). Efficacy and safety of anlotinib as maintenance treatment in extensive-stage small cell lung cancer: a single-armed single center retrospective study. Frontiers in Oncology, 1–9. https://doi.org/10.3389/fonc.2024.1462581
Chicago
Xiong, Jin, and Lei Xia. 2025. “Efficacy and Safety of Anlotinib as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer: A Single-Armed Single Center Retrospective Study.” Frontiers in Oncology, January, 1–9. doi:10.3389/fonc.2024.1462581.